Gary Lewis, University of Toronto, Canada, considers the role of the incretin hormones, GLP-1 and GIP, on insulin secretion and glucose levels and the effects of GLP-1 and dual receptor agonists not only on weight reduction but also on lipid profile.
Please login or create a FREE account to view this content
Educational Supporters of the 10th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:
Guest supporters:
